Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
Meera MohanSandra Susanibar-AdaniyaAmy BurosJuan Carlos Rico CrescencioMary J BurgessKatherine LusardiFaith DaviesGareth MorganFrits VanrheeMaurizio ZangariCarolina SchinkeSharmilan ThanendrarajanAtul KothariPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
We found a high incidence of E faecium and a low incidence of MRSA and Pseudomonas bacteremias following ASCT in our patient population. Survival analysis in our cohort suggests that the effect of underlying disease status and cumulative chemotherapy is critically important in determining outcomes related to bacteremia. Enterococcal bacteremias following ASCT were associated with significantly higher morbidity and mortality than non-enterococcal bacteremias.
Keyphrases
- mesenchymal stem cells
- risk factors
- stem cell transplantation
- high dose
- multiple myeloma
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- case report
- stem cells
- squamous cell carcinoma
- biofilm formation
- radiation therapy
- adipose tissue
- escherichia coli
- cystic fibrosis
- skeletal muscle
- free survival
- gram negative
- glycemic control
- weight loss